Cargando…
Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns
Preeclampsia (PE) is a disorder which affects 1-10% of pregnant women worldwide. It is characterised by hypertension and proteinuria in the later stages of gestation and can lead to maternal and perinatal morbidity and mortality. Other than the delivery of the foetus and the removal of the placenta,...
Autores principales: | Portelli, Maria, Baron, Byron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046127/ https://www.ncbi.nlm.nih.gov/pubmed/30050697 http://dx.doi.org/10.1155/2018/2632637 |
Ejemplares similares
-
A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women
por: Broumand, Farzaneh, et al.
Publicado: (2018) -
The potential value of diagnostic and predictive serum biomarkers for preeclampsia
por: Dijmărescu, Anda Lorena, et al.
Publicado: (2021) -
Evaluation of serum biomarkers for detection of preeclampsia severity in pregnant women
por: Kasraeian, Maryam, et al.
Publicado: (2018) -
DNA Methylation of Endoglin Pathway Genes in Pregnant Women With and
Without Preeclampsia
por: Rietze, Allison H, et al.
Publicado: (2020) -
The Effects of Vitamin D Supplement on Prevention of Recurrence of Preeclampsia in Pregnant Women with a History of Preeclampsia
por: Behjat Sasan, Sanam, et al.
Publicado: (2017)